Search Result

Results for "

miR-17

" in MedChemExpress (MCE) Product Catalog:

By Targets:	MicroRNA (22)
By Research Areas:	Cancer (22) Metabolic Disease (1)
Oligonucleotides:	miRNA mimics (5) miRNA agomirs (5) miRNA antagomirs (5) MicroRNAs (20) miRNA inhibitors (5) Antisense Oligonucleotides (2)

Inhibitors & Agonists

Oligonucleotides

Targets Recommended: 17β-HSD

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-139290A

RGLS4326 sodium RG4326 sodium	MicroRNA	Cancer
RGLS4326 sodium is a first-in-class, short oligonucleotide inhibitor of *microRNA-17* (miR-17). RGLS4326 sodium can be used for the research of autosomal dominant polycystic kidney disease (ADPKD). RGLS4326 sodium inhibits miR-17 function in HeLa cells with an EC₅₀ value of 28.3 nM .

HY-139290

RGLS4326 RG4326	MicroRNA	Metabolic Disease Cancer
RGLS4326 (RG4326) is a first-in-class, short oligonucleotide inhibitor of *microRNA-17* (miR-17). RGLS4326 can be used for the research of autosomal dominant polycystic kidney disease (ADPKD). RGLS4326 inhibits miR-17 function in HeLa cells with an EC₅₀ value of 28.3 nM .

HY-R00325

*hsa-miR-17-3p mimic*	MicroRNA	Cancer
hsa-miR-17-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-17-3p mimic hsa-miR-17-3p mimic

HY-R00326

*hsa-miR-17-5p mimic*	MicroRNA	Cancer
hsa-miR-17-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-17-5p mimic hsa-miR-17-5p mimic

HY-R02695

*mmu-miR-17-3p mimic*	MicroRNA	Cancer
mmu-miR-17-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-miR-17-3p mimic mmu-miR-17-3p mimic

HY-R04249

*rno-miR-17-1-3p mimic*	MicroRNA	Cancer
rno-miR-17-1-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

rno-miR-17-1-3p mimic rno-miR-17-1-3p mimic

HY-R04250

*rno-miR-17-2-3p mimic*	MicroRNA	Cancer
rno-miR-17-2-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

rno-miR-17-2-3p mimic rno-miR-17-2-3p mimic

HY-RI00325

*hsa-miR-17-3p inhibitor*	MicroRNA	Cancer
hsa-miR-17-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-17-3p inhibitor hsa-miR-17-3p inhibitor

HY-RI00326

*hsa-miR-17-5p inhibitor*	MicroRNA	Cancer
hsa-miR-17-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-17-5p inhibitor hsa-miR-17-5p inhibitor

HY-RI02695

*mmu-miR-17-3p inhibitor*	MicroRNA	Cancer
mmu-miR-17-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-17-3p inhibitor mmu-miR-17-3p inhibitor

HY-RI04249

*rno-miR-17-1-3p inhibitor*	MicroRNA	Cancer
rno-miR-17-1-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

rno-miR-17-1-3p inhibitor rno-miR-17-1-3p inhibitor

HY-RI04250

*rno-miR-17-2-3p inhibitor*	MicroRNA	Cancer
rno-miR-17-2-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

rno-miR-17-2-3p inhibitor rno-miR-17-2-3p inhibitor

HY-R00325A

*hsa-miR-17-3p agomir*	MicroRNA	Cancer
hsa-miR-17-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-17-3p agomir hsa-miR-17-3p agomir

HY-R00326A

*hsa-miR-17-5p agomir*	MicroRNA	Cancer
hsa-miR-17-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-17-5p agomir hsa-miR-17-5p agomir

HY-R02695A

*mmu-miR-17-3p agomir*	MicroRNA	Cancer
mmu-miR-17-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-17-3p agomir mmu-miR-17-3p agomir

HY-R04249A

*rno-miR-17-1-3p agomir*	MicroRNA	Cancer
rno-miR-17-1-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

rno-miR-17-1-3p agomir rno-miR-17-1-3p agomir

HY-R04250A

*rno-miR-17-2-3p agomir*	MicroRNA	Cancer
rno-miR-17-2-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

rno-miR-17-2-3p agomir rno-miR-17-2-3p agomir

HY-RI00325A

*hsa-miR-17-3p antagomir*	MicroRNA	Cancer
hsa-miR-17-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-17-3p antagomir hsa-miR-17-3p antagomir

HY-RI00326A

*hsa-miR-17-5p antagomir*	MicroRNA	Cancer
hsa-miR-17-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-17-5p antagomir hsa-miR-17-5p antagomir

HY-RI02695A

*mmu-miR-17-3p antagomir*	MicroRNA	Cancer
mmu-miR-17-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-17-3p antagomir mmu-miR-17-3p antagomir

HY-RI04249A

*rno-miR-17-1-3p antagomir*	MicroRNA	Cancer
rno-miR-17-1-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

rno-miR-17-1-3p antagomir rno-miR-17-1-3p antagomir

HY-RI04250A

*rno-miR-17-2-3p antagomir*	MicroRNA	Cancer
rno-miR-17-2-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

rno-miR-17-2-3p antagomir rno-miR-17-2-3p antagomir

Cat. No.	Product Name		Classification